SGLT 2 INHIBITORS

Clinical trials for SGLT 2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT 2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Could a diabetes pill shield children's kidneys from protein damage?

Disease control Ongoing

This study tests whether dapagliflozin, a drug used for diabetes, can reduce protein in the urine and protect kidney function in children aged 4-18 with persistent proteinuria despite standard therapy. Ten participants will take the drug and have their urine protein and kidney fu…

Matched conditions: SGLT 2 INHIBITORS

Phase: NA • Sponsor: Al-Quds University • Aim: Disease control

Last updated May 17, 2026 06:52 UTC

SGLT 2 INHIBITORS

Get alerted when new SGLT 2 INHIBITORS trials appear

Could a diabetes pill shield children's kidneys from protein damage?